By the clinical team at Next Step Psychiatry • Lilburn, GA
When patients come to Next Step Psychiatry in Lilburn considering Spravato for treatment-resistant depression, one of their first questions is: “How long will this take to work?” After months or years of unsuccessful antidepressant treatment, the prospect of rapid improvement is tantalizing but also something they want to understand realistically. Let’s walk through the actual timeline.
During Your First Treatment: Immediate Effects
Within 5–10 minutes of administering Spravato nasal spray, you’ll begin to feel dissociation. The world might seem distant or slightly unreal. Some patients describe it as floating or dreamlike. Your body might feel heavy or light, depending on your neurochemistry. These acute dissociative effects peak around 20–30 minutes post-administration and fade over the next hour.
Some patients report that even during this first treatment, they experience a sense of emotional relief—the constant weight of depression lifting slightly. Others feel the dissociative effect is novel but tolerable. A few find it distressing, though this discomfort usually improves with subsequent treatments as patients know what to expect.
First Week: Early Signs
By the end of your first week of Spravato (typically 2 treatments), some patients notice mood improvement. They might report sleeping better, having slightly more energy, or noticing a small shift in their perspective. This early response, while not universal, is encouraging. Many describe a subtle but palpable difference—the heaviness is a bit lighter, negative thoughts are a touch less intrusive.
This early response is one of Spravato’s major advantages over traditional antidepressants. SSRIs and SNRIs usually take 4–6 weeks to show any effect. Spravato can work in days. For patients in severe depression who can barely function, this rapid shift can be life-changing.
Two to Three Weeks: Noticeable Improvement
By 2–3 weeks into treatment (typically 4–6 doses if on twice-weekly schedule), most responding patients report more substantial improvements. Depressive symptoms measurably decrease. Sleep improves. Appetite normalizes. Concentration becomes easier. The relentless negative thoughts that characterize depression are less constant. Patients report being able to engage in activities they’d abandoned due to depression.
At this point, we formally assess response using standardized depression rating scales. We’re looking for at least a 50% reduction in depressive symptoms compared to baseline. Most patients who will respond to Spravato show this level of improvement by week 2–3.
Week Four and Beyond: Consolidation
By week 4, improvement typically stabilizes or continues to increase. We transition from induction (twice-weekly) to continuation therapy (typically weekly). Many patients are in remission by this point—depression is substantially resolved, not just improved. Some patients continue improving beyond this point, reaching full remission by week 6–8.
Three to Six Months: Long-Term Response
With continued maintenance dosing, the benefits of Spravato sustain. We typically see patients weekly during the continuation phase (weeks 3–8), then transition to maintenance therapy every 1–2 weeks. At this point, the goal shifts from acute symptom reduction to preventing relapse.
Many patients at Next Step Psychiatry report that by 3 months, they feel like themselves again. The depression that had dominated their life for months or years has genuinely resolved. They sleep normally, enjoy activities, interact socially, and work productively. This sustained improvement is what makes Spravato truly valuable.
Individual Variation in Response Timeline
While this timeline is typical, individual variation exists. Some patients respond dramatically within one week. Others take 3–4 weeks to show meaningful response. A small percentage don’t respond at all (approximately 30% show less than 50% symptom reduction). Our role is to monitor carefully, adjust dosing if needed, and discuss next steps if Spravato alone isn’t working.
Factors affecting timeline include: severity of baseline depression, previous medication trials, coexisting medical conditions, substance use, sleep quality, and psychosocial stressors. A patient with moderate treatment-resistant depression in a supportive life situation might respond faster than a patient with severe depression and ongoing trauma.
What This Means for Your Commitment
Spravato requires commitment: twice-weekly clinic visits for 2 weeks, weekly visits for 4 weeks, then ongoing maintenance. Each session involves 2 hours at our Lilburn clinic (nasal spray, monitoring, and recovery time). This time investment is significant, but for patients who’ve been waiting months or years for relief, it’s usually worth it. The rapid timeline means you’re not waiting weeks for an answer about whether treatment will work—you’ll know within 2–3 weeks.
Combination with Therapy
We often recommend that patients combine Spravato with psychotherapy. Therapy helps address behavioral patterns and life circumstances that may have contributed to depression. The rapid antidepressant effect of Spravato gives patients the mental clarity and energy to engage more meaningfully in therapy.
Getting Started at Next Step Psychiatry
If you’re in Lilburn or the Atlanta metro area and wondering whether Spravato might work for you, the first step is a consultation. We’ll evaluate your history, confirm you meet criteria for treatment-resistant depression, discuss the timeline and commitment, and answer all your questions. For many patients, understanding the realistic timeline transforms Spravato from a mysterious treatment into a concrete, hopeful option.
Call 678-437-1659 to schedule your Spravato evaluation.
This article is for informational purposes only and is not a substitute for professional medical advice. If you or someone you know is in crisis, call 911 or the 988 Suicide & Crisis Lifeline.